Thrombophilia (Other Potential Genetic Risk Factors) Flashcards
Autosomal Dominant.
Asymptomatic unless combined with second risk.
Acquired: DIC, liver disease
Heparin Cofactor II Deficiency
Neutralizes Xa and in complex neutralizes tissue factor-VIIa complex.
Tissue Factor Pathway Inhibitor Variant
B and A1 subgroups
Higher risk for venous thrombosis.
High levels of vWF and VIIa.
ABO blood group
Amino acid metabolized to methionine.
Associated with venous and arterial thrombosis.
Lab:
Ion exchange chromatography
Hyperhomocysteinemia
Cleaved by thrombin to form fibrin.
Dysfibrinogenemia:
20% recurrent venous or arterial thromboembolism.
Fibrin resistant to plasmin lysis.
Reduced plasminogen activation.
Mutated fibrinogen-forms high fiber clots.
Lab:
TT and reptilase time(not affected by heparin)
Immunologic assay
Fibrinogen Disorders
Increased plasma VIII and vWF.
Increased risk of thrombotic disease
Elevated Factor VIII and vWF
Increased APTT
No bleeding
Defective thrombus stability
Factor VIII and thromboembolic disease
tPA and PAI
Inadequate stores/release of tPA
Excess release of PAI
Contribute to thrombosis
Fibrinolytic System Disorders